InvestorsHub Logo
Followers 65
Posts 9468
Boards Moderated 0
Alias Born 01/09/2012

Re: None

Wednesday, 01/16/2013 10:02:11 AM

Wednesday, January 16, 2013 10:02:11 AM

Post# of 92256
There is something here that we don't understand. Given the PR's and all this talk of game changing technology and a tie with some macular outfit the stock is refusing to budge from this range.

Now part of it is the huge unexercised warrant overhang which is scaring away long term buyers because they equate it future dilution and lower pps. the other part is the additional $3.5 to $5 million more of capital needed to finance the business plan. this too is equated with future dilution.

But what is quite worrisome is why people are not seeing through this to the supposed game changing technology, the number of potential applications as listed in te 10K - did anybody notice they did not list Erictile dysfunction - and the hiring of Atlas and the ONGOING search for partners, and bidding the stock up substantially...

There are plenty of Bio pharma stocks that sport $100, $500 evena $1 billion dollar market caps and have zero revenues....

There is something in all of this that is not resulting in the big buying by the big money....there is something in the research etc. that is not convincing....

i wish I knew what it was.....and no it isn't that people have not heard of drop...please....